Amicus Therapeutics ApS: Financial statements 2024
CVR: 39359340
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Amicus Therapeutics ApS (CVR 39359340) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,987,087 and a net result of DKK 16,475 compared with DKK 52,221 the year before. That is an increase of 14.7% compared with the year before. Equity in the 2024 report amounted to DKK 309,637. The solvency ratio was 9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,987,087
- Profit/Loss
- DKK 16,475
- Equity
- DKK 309,637
- Total Assets
- DKK 3,426,179
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2 mio. | 16 t. | 310 t. | 1 |
| 2023 | - | 1.7 mio. | 52 t. | 355 t. | 1 |
| 2022 | - | 1.6 mio. | 54 t. | 303 t. | 1 |
| 2021 | - | 644 t. | 19 t. | 249 t. | 1 |
| 2020 | - | 490 t. | 22 t. | 230 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 7, 2024, Jessica Alice Stephens-Brown has joined the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, Ana Rogovic has joined the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, Charlotte Ann Galvin has left the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, David Malcolm Lewis has left the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, Ana Rogovic is registered as director of Amicus Therapeutics ApS.
As of October 7, 2024, Charlotte Ann Galvin has stepped down as director of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK 1,732,212, and the net result was DKK 52,221.
As of February 1, 2024, David Malcolm Lewis has joined the board of directors of Amicus Therapeutics ApS.
As of January 31, 2024, Anita Jane Clifford has left the board of directors of Amicus Therapeutics ApS.
About Amicus Therapeutics ApS
Amicus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Richard Gideon Morris. The board consists of Richard Gideon Morris (chair), Brian Keogh and Steven John Green. The company is owned by Amicus Therapeutics UK Ltd.. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,441,140 and a net result of DKK 115,004 compared with DKK 16,475 the year before. Equity in the 2025 report amounted to DKK 424,641.